Jiang Zhu - Search Results

Year	Number of Results
2000	1
2002	5
2003	9
2004	11
2005	16
2006	9
2007	16
2008	30
2009	24
2010	47
2011	35
2012	44
2013	58
2014	68
2015	55
2016	57
2017	76
2018	76
2019	80
2020	105
2021	116
2022	74

1

Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.

Lu Y, Xue J, Deng T, Zhou X, Yu K, Deng L, Huang M, Yi X, Liang M, Wang Y, Shen H, Tong R, Wang W, Li L, Song J, Li J, Su X, Ding Z, Gong Y, Zhu J, Wang Y, Zou B, Zhang Y, Li Y, Zhou L, Liu Y, Yu M, Wang Y, Zhang X, Yin L, Xia X, Zeng Y, Zhou Q, Ying B, Chen C, Wei Y, Li W, Mok T. Lu Y, et al. Among authors: zhu j. Nat Med. 2020 May;26(5):732-740. doi: 10.1038/s41591-020-0840-5. Epub 2020 Apr 27. Nat Med. 2020. PMID: 32341578 Clinical Trial.

2

RIG-I regulates myeloid differentiation by promoting TRIM25-mediated ISGylation.

Wu SF, Xia L, Shi XD, Dai YJ, Zhang WN, Zhao JM, Zhang W, Weng XQ, Lu J, Le HY, Tao SC, Zhu J, Chen Z, Wang YY, Chen S. Wu SF, et al. Among authors: zhu j. Proc Natl Acad Sci U S A. 2020 Jun 23;117(25):14395-14404. doi: 10.1073/pnas.1918596117. Epub 2020 Jun 8. Proc Natl Acad Sci U S A. 2020. PMID: 32513696 Free PMC article.

3

Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myeloma.

Xu J, Chen LJ, Yang SS, Sun Y, Wu W, Liu YF, Xu J, Zhuang Y, Zhang W, Weng XQ, Wu J, Wang Y, Wang J, Yan H, Xu WB, Jiang H, Du J, Ding XY, Li B, Li JM, Fu WJ, Zhu J, Zhu L, Chen Z, Fan XF, Hou J, Li JY, Mi JQ, Chen SJ. Xu J, et al. Among authors: zhu j. Proc Natl Acad Sci U S A. 2019 May 7;116(19):9543-9551. doi: 10.1073/pnas.1819745116. Epub 2019 Apr 15. Proc Natl Acad Sci U S A. 2019. PMID: 30988175 Free PMC article. Clinical Trial.

4

Distinct immune signatures discriminate between asymptomatic and presymptomatic SARS-CoV-2^pos subjects.

Yu S, Di C, Chen S, Guo M, Yan J, Zhu Z, Liu L, Feng R, Xie Y, Zhang R, Chen J, Wang M, Wei D, Fang H, Yin T, Huang J, Chen S, Lu H, Zhu J, Qu J. Yu S, et al. Among authors: zhu j. Cell Res. 2021 Nov;31(11):1148-1162. doi: 10.1038/s41422-021-00562-1. Epub 2021 Sep 24. Cell Res. 2021. PMID: 34561618 Free PMC article.

5

Specific breast cancer prognosis-subtype distinctions based on DNA methylation patterns.

Zhang S, Wang Y, Gu Y, Zhu J, Ci C, Guo Z, Chen C, Wei Y, Lv W, Liu H, Zhang D, Zhang Y. Zhang S, et al. Among authors: zhu j. Mol Oncol. 2018 Jun;12(7):1047-1060. doi: 10.1002/1878-0261.12309. Epub 2018 May 21. Mol Oncol. 2018. PMID: 29675884 Free PMC article.

6

Angiogenesis-Related Gene Expression Signatures Predicting Prognosis in Gastric Cancer Patients.

Ren H, Zhu J, Yu H, Bazhin AV, Westphalen CB, Renz BW, Jacob SN, Lampert C, Werner J, Angele MK, Bösch F. Ren H, et al. Among authors: zhu j. Cancers (Basel). 2020 Dec 8;12(12):3685. doi: 10.3390/cancers12123685. Cancers (Basel). 2020. PMID: 33302481 Free PMC article.

7

Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics.

Wang Y, Zhang S, Li F, Zhou Y, Zhang Y, Wang Z, Zhang R, Zhu J, Ren Y, Tan Y, Qin C, Li Y, Li X, Chen Y, Zhu F. Wang Y, et al. Among authors: zhu j. Nucleic Acids Res. 2020 Jan 8;48(D1):D1031-D1041. doi: 10.1093/nar/gkz981. Nucleic Acids Res. 2020. PMID: 31691823 Free PMC article.

8

HPV E7 inhibits cell pyroptosis by promoting TRIM21-mediated degradation and ubiquitination of the IFI16 inflammasome.

Song Y, Wu X, Xu Y, Zhu J, Li J, Zou Z, Chen L, Zhang B, Hua C, Rui H, Zheng Q, Zhou Q, Wang Q, Cheng H. Song Y, et al. Among authors: zhu j. Int J Biol Sci. 2020 Sep 13;16(15):2924-2937. doi: 10.7150/ijbs.50074. eCollection 2020. Int J Biol Sci. 2020. PMID: 33061806 Free PMC article.

9

circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer.

Kong Y, Li Y, Luo Y, Zhu J, Zheng H, Gao B, Guo X, Li Z, Chen R, Chen C. Kong Y, et al. Among authors: zhu j. Mol Cancer. 2020 May 4;19(1):82. doi: 10.1186/s12943-020-01205-6. Mol Cancer. 2020. PMID: 32366257 Free PMC article.

10

SLFN5 suppresses cancer cell migration and invasion by inhibiting MT1-MMP expression via AKT/GSK-3β/β-catenin pathway.

Wan G, Liu Y, Zhu J, Guo L, Li C, Yang Y, Gu X, Deng LL, Lu C. Wan G, et al. Among authors: zhu j. Cell Signal. 2019 Jul;59:1-12. doi: 10.1016/j.cellsig.2019.03.004. Epub 2019 Mar 4. Cell Signal. 2019. PMID: 30844429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results